Publizoom

Award notice Supplies

Irinotecan iv

Notice published in French. The AI analysis summarises it for you in your language.

Public buyer
MercurHosp ASBL
Erpent
Place of performance
5101 Erpent, Namur
not published: buyer's address
Amount awarded
€37,542 excl. VAT
Planned end of contract
1 January 2029
likely re-tender around July 2028
Bids received
2
Procedure
Open procedure
Any company may submit a bid.
Publication
11 March 2025
Notice language
French

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Marché de fourniture d’irinotécan 40mg, 100mg, 300 mg et 500mg en solution pour perfusion par voie intraveineuse.

Awarded to

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below
€269,390
Median
€449,863
A quarter above
€962,736

Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

ContractWinnerAmount
Fourniture d'azaticidine
MercurHosp ASBL · 3 August 2026
Fresenius Kabi €67,433
Fourniture d'analogues de la somatostatine
MercurHosp ASBL · 1 October 2025
Pharmanovia Benelux B.V.
NOVARTIS PHARMA
€606,086
Générateurs de Technétium (99M Tc) et produits radiopharmaceutiques
MercurHosp ASBL · 1 October 2025
GE HEALTHCARE
CISBIO International
Curium Belgium
€12,256,476
ATOSIBAN IV
MercurHosp ASBL · 30 September 2025
FERRING €391,336
Meropenem injectable
MercurHosp ASBL · 30 September 2025
Fresenius Kabi €440,575

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 157064-2025.